Campaign Unavailable

The Food and Drug Administration has made the informal decision to regulate transgenic fish under its authority to review new animal drugs. Given the potential toxicity, allergenicity, and aquaculture diseases posed by the commercialization of transgenic fish, CFS is demanding that the FDA adopt a pre-market regulatory review that does not ignore these potential human health safety concerns.